FDA approves Lilly's (LLY) treatment for episodic cluster headache that reduces the frequency of attacks
The U.S. Food and Drug Administrationtoday approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)